Esperion Therapeutics (ESPR)
NASDAQ:ESPR
Want to see ESPR full AI Analyst Report?
Esperion (ESPR) Ownership Overview
1.80% Insiders
13.59% Mutual Funds
26.39% Other Institutional Investors
11.61% ETFs
46.61% Public Companies and
Individual Investors
The ownership structure of Esperion (ESPR) stock is a mix of institutional, retail, and individual investors. Approximately 51.59% of the company’s stock is owned by Institutional Investors, 1.80% is owned by Insiders, and 46.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 18, 2026 | xxxxxxxxxxxxx | $69316 | |
Mar 18, 2026 | xxxxxxxxxxxxx | $17345 | |
Mar 18, 2026 | xxxxxxxxxxxxx | $15412 | |
Jan 21, 2026 | xxxxxxxxxxxxx | $4864 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $194710 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $348057 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $7197966 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,369,627 | Institution | 4.80% | 38,964,325 | |
| 10,609,627 | Institution | 4.12% | 33,420,325 | |
| 10,189,965 | Institution | 3.95% | 32,098,390 | |
| 9,111,628 | Institution | 3.54% | 28,701,628 | |
| 3,466,399 | Institution | 1.35% | 10,919,157 | |
| 2,827,950 | Institution | 1.10% | 8,908,043 | |
| 2,626,995 | Institution | 1.02% | 8,275,034 | |
| 2,556,024 | Institution | 0.99% | 8,051,476 | |
| 2,433,878 | Institution | 0.94% | 7,666,716 | |
| 2,362,912 | Institution | 0.92% | 7,443,173 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,609,627 | Institution | 4.12% | 33,420,325 | |
| 10,189,965 | Institution | 3.95% | 32,098,390 | |
| 3,466,399 | Institution | 1.35% | 10,919,157 | |
| 2,556,024 | Institution | 0.99% | 8,051,476 | |
| 2,362,912 | Institution | 0.92% | 7,443,173 | |
| 1,364,753 | Institution | 0.53% | 4,298,972 | |
| 894,107 | Institution | 0.35% | 2,816,437 | |
| 829,785 | Institution | 0.32% | 2,613,823 | |
| 724,980 | Institution | 0.28% | 2,283,687 | |
| 695,906 | Institution | 0.27% | 2,192,104 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,525,646 | Institution | 2.92% | 15,051,292 | |
| 5,650,451 | Institution | 2.19% | 17,798,921 | |
| 2,679,129 | Institution | 1.04% | 5,358,258 | |
| 2,429,635 | Institution | 0.94% | 7,653,350 | |
| 2,376,842 | Institution | 0.92% | 7,487,052 | |
| 1,356,642 | Institution | 0.53% | 4,273,422 | |
| 1,216,318 | Institution | 0.47% | 2,432,636 | |
| 713,556 | Institution | 0.28% | 1,427,112 | |
| 654,280 | Institution | 0.25% | 2,060,982 | |
| 623,790 | Institution | 0.24% | 1,964,939 |
FAQ
Who Owns Esperion Therapeutics (ESPR)?
According to the latest TipRanks data, approximately 26.39% of the company's stock is held by institutional investors, 1.80% is held by insiders, and 46.61% is held by retail investors.
What percentage of Esperion Therapeutics (ESPR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.39% of Esperion Therapeutics (ESPR) stock is held by institutional investors.
What percentage of Esperion Therapeutics (ESPR) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.61% of Esperion Therapeutics (ESPR) stock is held by retail investors.
Who owns the most shares of Esperion Therapeutics (ESPR)?
Vanguard owns the most shares of Esperion Therapeutics (ESPR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.